FDA approves new drug for anthrax poisoning

Federal health officials say they have approved an infusible drug to treat patients who have been exposed to anthrax.

The Food and Drug Administration approved Anthrasil for use in combination with older antibiotics to treat inhalation anthrax, which can cause serious injury and death. The condition occurs when the that carry anthrax are inhaled.

Anthrasil is made from the blood plasma of people who have been vaccinated against anthrax. They carry antibodies against the toxic bacteria.

The drug's development was funded by the U.S. government's Biomedical Advanced Research and Development Authority, which stockpiles vaccines, drugs and equipment for use during pandemics and other health emergencies.

The FDA approved the drug based efficacy data from animal studies and human safety studies. It is manufactured by Cangene Corporation of Canada.

© 2015 The Associated Press. All rights reserved.

Citation: FDA approves new drug for anthrax poisoning (2015, March 25) retrieved 29 March 2024 from https://medicalxpress.com/news/2015-03-fda-drug-anthrax-poisoning.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA approves new drug for inhaled anthrax

4 shares

Feedback to editors